Evaluation of Renal Adverse Effects of Combination Anti-retroviral Therapy including Tenofovir in HIV-infected Patients
Purpose. In order to maintain plasma HIV-RNA concentration in HIV-infected patients, below the detection limit combination anti-retroviral therapy (cART) are used. Although the nucleoside/nucleotide reverse transcriptase inhibitor, tenofovir disoproxil fumarate (TDF) is a first-line drug commonly us...
Saved in:
Main Authors: | Hiroyuki Tanaka (Author), Mariko Arai (Author), Yoshinori Tomoda (Author), Tatsuhiko Wada (Author), Kazuo Yago (Author), Mitsutoshi Satoh (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2013-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the Efficacy and Safety of Changes in Antiretroviral Regimens for HIV-infected Patients
by: Hiroyuki Tanaka, et al.
Published: (2014) -
Analysis of patients with hypomagnesemia using the Japanese Adverse Drug Event Report database (JADER)
by: Hiroyuki Tanaka, et al.
Published: (2018) -
Association between tenofovir plasma trough concentrations in the early stage of administration and discontinuation of up to five years tenofovir disoproxil fumarate due to renal function-related adverse events in Japanese HIV-1 infected patients
by: Hiroki Yagura, et al.
Published: (2024) -
An overview of tenofovir and renal disease for the HIV-treating clinician
by: Willem D.F. Venter, et al.
Published: (2018) -
Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
by: Yang YM, et al.
Published: (2017)